Google Übersetzer
Tempest Therapeutics Inc
About
Tempest Therapeutics Inc (NASDAQ:TPST) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting
Apr 22 2026
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
Apr 14 2026
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
Mar 30 2026
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Mar 23 2026
Tempest Therapeutics Announces Up To $6 Million Private Placement
Recent Videos
Tempest Therapeutics Deep Dive: The $250M Valuation Gap
Mar 28, 2026
23 Marzo 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Mar 23, 2026
23 March 26. Biotech Stock News. Daily Recap2 #English #Shorts $XBI #trading #biotechnews #dailynews
Mar 23, 2026
Cómo invertir en Tempest Therapeutics Inc (TPST) paso a paso
Mar 02, 2026
Financials
Revenue
$0
Market Cap
$22.81 M
EPS
-6.33